Skip to main content

Society of Dermatology Physician Assistants (SDPA) Summer, 2025

Filter
Close
Content type:
Bimekizumab impact on flare in hidradenitis suppurativa over 2 years: Data from BE HEARD EXT
Naik B Haley, Daveluy Steven, Errol Prens, et al.
Poster
Bimekizumab maintenance of response at every visit over 4 years in patients with psoriasis achieving clear skin at Week 16: Results from four phase 3 trials
Lebwohl Mark, Richard B Warren, Foley Peter, et al.
Poster
Bimekizumab efficacy and safety through 5 years in patients with moderate to severe plaque psoriasis in the US and Canada
Blauvelt Andrew, Khattri Saakshi, Rich Phoebe, et al.
Poster